000 01393 a2200385 4500
005 20250517045525.0
264 0 _c20160506
008 201605s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0134921
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhan, Wasif Ali
245 0 0 _aEfficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
_h[electronic resource]
260 _bPloS one
_c2015
300 _ae0134921 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBangladesh
650 0 4 _aCholera
_xdrug therapy
650 0 4 _aCiprofloxacin
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Resistance, Bacterial
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNalidixic Acid
_xpharmacology
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRetrospective Studies
650 0 4 _aVibrio cholerae
_xgrowth & development
700 1 _aSaha, Debasish
700 1 _aAhmed, Sabeena
700 1 _aSalam, Mohammed Abdus
700 1 _aBennish, Michael Louis
773 0 _tPloS one
_gvol. 10
_gno. 8
_gp. e0134921
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0134921
_zAvailable from publisher's website
999 _c25166973
_d25166973